Lithuania - Monoclonal antibodies for the treatment of metastatic colon or rectal cancer (Cetuximab and/or Panitumumab)
By: State sick fund under the Ministry of Health📍 LithuaniaOpen
Key Information
| Reference | GB-757088-2026 |
|---|
| Deadline | Dec 3, 2026 12:00 AM |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Lithuania |
|---|
| Address | European century1, Vilnius, 09308, Lithuania |
|---|
| Published | Nov 2, 2026 |
|---|
Description
2. Procedure2.1.ProcedureTitle: Monoclonal antibodies for the treatment of metastatic colon or rectal cancer (Cetuximab and/or Panitumumab)Description: The procuring organization intends to purchase m...
Full details are available after unlocking this tender.